Pyxis Oncology Announces $50 Million Private Placement - Seite 3
BOSTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) - Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that it has agreed to sell …